Cellular pharmacology of vinca alkaloid resistance and its circumvention (Q54485892)

30 May 2018

title

Cellular pharmacology of vinca alkaloid resistance and its circumvention (English)

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

2 August 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

2 August 2023

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

2 August 2023

author name string

W. T. Beck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6089511

2 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6089511

2 August 2023

publication date

1 January 1984

1 reference

30 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0065257184900153?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

https://api.elsevier.com/content/article/PII:0065257184900153?httpAccept=text/plain

2 August 2023

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Advances in Enzyme Regulation

2 August 2023

published in

1 reference

30 May 2018

volume

22

1 reference

30 May 2018

page(s)

207-227

1 reference

30 May 2018

Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivo.

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo

2 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response

2 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Reduced permeability in CHO cells as a mechanism of resistance to colchicine

2 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Membrane-Mediated Drug Resistance and Phenotypic Reversion to Normal Growth Behavior of Chinese Hamster Cells 2

2 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity

2 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts

2 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

2 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Alterations in cell surface membranes in Chinese hamster lung cell resistant to adriamycin.

2 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Increased synthesis of a low molecular weight protein in vincristine-resistant cells

2 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Colchicine resistance in mammalian cell lines

2 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

2 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells

2 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia

2 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia

2 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells

2 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia

2 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Enhanced efflux of actinomycin D, vincristine, and vinblastine in adriamycin-resistant subline of P388 leukemia

2 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia

2 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Correlates of vincristine resistance in four murine tumor cell lines

2 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

2 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.

2 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug

2 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Potentiation of chemotherapeutic effect of vincristine in vincristine resistant tumor bearing mice by calmodulin inhibitor clomipramine

2 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme.

2 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Tubulin binding affinities of podophyllotoxin and colchicine analogues

2 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells

2 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression

2 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Modulation of membrane drug permeability in Chinese hamster ovary cells

2 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

The transport of steroids into animal cells in culture.

2 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Uptake of Taurocholic Acid into Isolated Rat-Liver Cells

2 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites Carcinoma

2 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Limitations on the use of phenothiazines and local anaesthetics as indicators of calmodulin function in intact cells

2 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

2 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase

2 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine

2 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Can calmodulin inhibitors be used to probe calmodulin effects?

2 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

The affinity of various phenothiazine drugs for membranes of intact human erythrocytes and their membrane-transforming activity

2 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Multiple effects of reserpine on chromaffin-granule in membranes

2 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Mechanisms of Calcium Antagonist-Induced Vasodilation

2 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Prevention of vinblastine-induced cytotoxicity by ruthenium red

2 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

Impairment by ruthenium red of anticancer drug cytotoxicity in CCRF-CEM cells

2 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0065-2571(84)90015-3

2 August 2023

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018